K024019 · Aircast, Inc. · JOW · Jun 3, 2003 · Cardiovascular
Device Facts
Record ID
K024019
Device Name
ARTERIALFLOW SYSTEM, MODEL 32A
Applicant
Aircast, Inc.
Product Code
JOW · Cardiovascular
Decision Date
Jun 3, 2003
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.5800
Device Class
Class 2
Attributes
Therapeutic
Intended Use
For the improvement of blood circulation in the upper and lower extremities to help prevent and reduce complications of poor circulation.
Device Story
Arterialflow System (Model 32A) is a compressible limb sleeve device. It functions by applying external compression to limbs to enhance blood circulation. Used in clinical or home settings under prescription, it is operated by patients or healthcare providers. The device provides mechanical compression to the extremities, which aids in venous and arterial blood flow, thereby reducing complications related to poor circulation. It serves as a non-invasive therapeutic intervention for circulatory support.
Clinical Evidence
No clinical data provided; substantial equivalence based on technological characteristics and intended use.
Technological Characteristics
Compressible limb sleeve; mechanical compression principle; Class II device (21 CFR 870.5800); Product Code JOW.
Indications for Use
Indicated for patients requiring improved blood circulation in upper and lower extremities to prevent or reduce complications associated with poor circulation.
Regulatory Classification
Identification
A compressible limb sleeve is a device that is used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb.
Related Devices
K131146 — ARTASSIST AND VENASSIST · Aci Medical, LLC · Feb 10, 2014
K102582 — ARTERIOFLOW MODEL 7500 SEQUENTIAL COMPRESSION DEVICE · Devon Medical, Inc. · Oct 7, 2010
K042217 — FLOWMEDIC, MODEL 220 · Flowmedic (Israel), Ltd. · Jan 12, 2005
K072666 — BIOARTERIAL PLUS, ARTERIAL BLOOD FLOW ENHANCEMENT SYSTEM · Bio Compression Systems, Inc. · Nov 5, 2007
K211937 — SyneCare 1100 Deep Vein Thrombosis Prevention Therapy System · Jiangsu Synecoun Medical Technology Co., Ltd. · Nov 18, 2021
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling a stylized caduceus or a representation of human figures in profile.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN - 3 2003
Aircast, Inc. c/o Mr. Stephen L. Kenney Director of Quality 92 River Road Summit, NJ 07902-0709
Re: K024019
Trade Name: Arterialflow System, Model 32A Regulation Number: 21 CFR 870.5800 Regulation Name: Compressible Limb Sleeve Regulatory Class: Class II (two) Product Code: JOW Dated: May 16, 2003 Received: May 20, 2003
Dear Mr. Kenney:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
{1}------------------------------------------------
Page 2 - Mr. Stephen L. Kenney
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
A.R. D.Z. M.R.
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and . Radiological Health
Enclosure
{2}------------------------------------------------
Page 1_of 1
510(k) Number (if known): K024019
ArterialFlow Device Name:
Indications for Use: For the improvement of blood circulation in the upper and lower extremities to help prevent and reduce complications of poor circulation.
> (PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED.) Concurrence of CDRH, Office of Device Evaluation (ODE)
Oath Teh
(Division Sign-Off)
Division of Cardiovascular Devices
**510(k) Number** K024019
(Optional Format 3-10-98)
Prescription Use Only
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.